| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2003-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347783ed288dc880b5af217dc8582162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dff815b7b1686d84a4c9d4f73d6d8aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_475faf37d022a17eb8a9819ea4d3a37b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0771903bd52d748b065fa30b0e6930e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a19ffb83d885fa54e262b0ceaf100e |
| publicationDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PE-20040532-A1 |
| titleOfInvention |
FEXOFENADINE-BASED DRUG FORMULATION |
| abstract |
REFERS TO A PHARMACEUTICAL COMPOSITION CONTAINING FEXOFENADINE USING APPROPRIATE DOSAGES OF 240 mg AND 120 mg. SAID COMPOUND IS A SELECTIVE H1 INHIBITOR INDICATED FOR THE TREATMENT OF MILD TO MODERATE ASTHMA, ALLERGIC RHINIIS AND CHRONIC IDEOPATHIC URTICARIA |
| priorityDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |